TY - JOUR T1 - Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis. JO - Health technology assessment (Winchester, England) PY - 2004/06/01 AU - Tappenden P AU - Chilcott JB AU - Eggington S AU - Oakley J AU - McCabe C ED - VL - 8 IS - 27 Y2 - 2025/11/06 ER -